Online citations, reference lists, and bibliographies.
← Back to Search

Atezolizumab, Vemurafenib, And Cobimetinib As First-line Treatment For Unresectable Advanced BRAFV600 Mutation-positive Melanoma (IMspire150): Primary Analysis Of The Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas, Caroline Robert, Karl Lewis, Svetlana Protsenko, Rodrigo P Pereira, Thomas Eigentler, Piotr Rutkowski, Lev Demidov, Georgy Moiseevich Manikhas, Yibing Yan, Kuan-Chieh Huang, Anne Uyei, Virginia McNally, Grant A McArthur, Paolo A Ascierto

Save to my Library
Download PDF
Analyze on Scholarcy
Share